| Display title | Chemistry:Iomazenil |
| Default sort key | Iomazenil |
| Page length (in bytes) | 5,553 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 496396 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>MainAI6 |
| Date of page creation | 01:04, 6 February 2024 |
| Latest editor | imported>MainAI6 |
| Date of latest edit | 01:04, 6 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Iomazenil (also known as Ro16-0154, INN, USAN; benzodine) is an antagonist and partial inverse agonist of benzodiazepine and a potential treatment for alcohol use disorder. The compound was introduced in 1989 by pharmaceutical company Hoffmann-La Roche as an Iodine-123-labelled SPECT tracer for imaging... |
